Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.

Uno H, Tian L, Cai T, Kohane IS, Wei LJ.

Stat Med. 2013 Jun 30;32(14):2430-42. doi: 10.1002/sim.5647. Epub 2012 Oct 5.

2.

Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data.

Uno H, Cai T, Tian L, Wei LJ.

Biometrics. 2011 Dec;67(4):1389-96. doi: 10.1111/j.1541-0420.2011.01600.x. Epub 2011 Apr 19.

3.

Interpreting incremental value of markers added to risk prediction models.

Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P.

Am J Epidemiol. 2012 Sep 15;176(6):473-81. Epub 2012 Aug 8.

4.

Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.

Li J, Jiang B, Fine JP.

Biostatistics. 2013 Apr;14(2):382-94. doi: 10.1093/biostatistics/kxs047. Epub 2012 Nov 28.

5.

Assessment of performance of survival prediction models for cancer prognosis.

Chen HC, Kodell RL, Cheng KF, Chen JJ.

BMC Med Res Methodol. 2012 Jul 23;12:102. doi: 10.1186/1471-2288-12-102.

6.

Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.

Zheng Y, Parast L, Cai T, Brown M.

Lifetime Data Anal. 2013 Jul;19(3):350-70. doi: 10.1007/s10985-012-9239-z. Epub 2012 Dec 20.

7.

Can survival prediction be improved by merging gene expression data sets?

Yasrebi H, Sperisen P, Praz V, Bucher P.

PLoS One. 2009 Oct 23;4(10):e7431. doi: 10.1371/journal.pone.0007431.

8.

A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.

Hilden J, Gerds TA.

Stat Med. 2014 Aug 30;33(19):3405-14. doi: 10.1002/sim.5804. Epub 2013 Apr 2.

PMID:
23553436
9.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS.

Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12.

PMID:
17569110
10.

Landmark risk prediction of residual life for breast cancer survival.

Parast L, Cai T.

Stat Med. 2013 Sep 10;32(20):3459-71. doi: 10.1002/sim.5776. Epub 2013 Mar 14.

11.

Evaluating a new marker for risk prediction: decision analysis to the rescue.

Baker SG, Kramer BS.

Discov Med. 2012 Sep;14(76):181-8. Review.

13.

Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.

Steyerberg EW, Vedder MM, Leening MJ, Postmus D, D'Agostino RB Sr, Van Calster B, Pencina MJ.

Biom J. 2015 Jul;57(4):556-70. doi: 10.1002/bimj.201300260. Epub 2014 Jul 18.

PMID:
25042996
14.

Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.

Mihaescu R, van Zitteren M, van Hoek M, Sijbrands EJ, Uitterlinden AG, Witteman JC, Hofman A, Hunink MG, van Duijn CM, Janssens AC.

Am J Epidemiol. 2010 Aug 1;172(3):353-61. doi: 10.1093/aje/kwq122. Epub 2010 Jun 18.

15.

Assessing the incremental value of diagnostic and prognostic markers: a review and illustration.

Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B.

Eur J Clin Invest. 2012 Feb;42(2):216-28. doi: 10.1111/j.1365-2362.2011.02562.x. Epub 2011 Jul 5.

16.

Evaluating a New Risk Marker's Predictive Contribution in Survival Models.

Liu M, Kapadia AS, Etzel CJ.

J Stat Theory Pract. 2010 Dec 1;4(4):845-855.

17.

Clinically relevant measures of fit? A note of caution.

Cook NR.

Am J Epidemiol. 2012 Sep 15;176(6):488-91. Epub 2012 Aug 8.

18.

Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.

Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW.

Med Decis Making. 2013 May;33(4):490-501. doi: 10.1177/0272989X12470757. Epub 2013 Jan 11. Review.

19.

Robust combination of multiple diagnostic tests for classifying censored event times.

Cai T, Cheng S.

Biostatistics. 2008 Apr;9(2):216-33. Epub 2007 Dec 3.

20.

Assessing the performance of prediction models: a framework for traditional and novel measures.

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW.

Epidemiology. 2010 Jan;21(1):128-38. doi: 10.1097/EDE.0b013e3181c30fb2.

Items per page

Supplemental Content

Write to the Help Desk